PTC Therapeutics Commercial Paper Liability (Quarterly) Insights

PTC Therapeutics, Inc. (PTCT)

68.17 +0.07 (+0.10%) USD | NASDAQ | Feb 27, 16:00

68.17 0.00 (0.00%) After-Hours: 19:46

View Commercial Paper Liability (Quarterly) for PTCT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Quarterly) Benchmarks

Start Trial

BioMarin Pharmaceutical, Inc.	--
Sarepta Therapeutics, Inc.	--
Ardelyx, Inc.	--
Spyre Therapeutics, Inc.	--
Ovid Therapeutics, Inc.	--